Harrow health, inc. (HROW)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
ASSETS
Current assets
Cash and cash equivalents, including restricted cash of $200

4,124

4,949

3,631

4,193

4,265

6,838

6,315

4,170

2,892

4,219

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investment in Eton Pharmaceuticals

14,350

25,200

22,120

27,650

28,000

21,420

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

3,867

4,165

7,396

8,853

2,362

5,441

11,821

2,685

6,556

10,051

2,898

8,211

10,363

12,101

14,201

15,579

16,827

17,970

18,979

10,035

10,990

7,717

146

146

2

5

291

Restricted cash and short-term investments

-

-

-

-

-

-

-

-

-

-

200

200

200

200

450

150

150

150

150

150

150

150

150

150

50

50

50

-

-

0

-

-

-

-

-

-

-

Accounts receivable, net

2,029

2,009

2,815

2,223

2,194

1,914

1,731

1,360

1,474

1,529

2,625

2,856

3,036

2,921

2,233

1,922

943

840

701

579

436

81

68

81

1

0

-

-

-

-

-

-

-

-

-

-

-

Insurance receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

841

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventories

3,989

3,301

2,443

2,652

2,388

1,834

2,524

2,216

2,040

2,249

2,374

1,832

2,044

1,841

1,902

1,441

1,233

1,412

1,273

793

711

373

351

172

-

0

-

-

-

-

-

-

-

-

-

-

-

Assets held for sale

-

-

-

-

-

-

-

-

-

-

-

520

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Due from Pharmacy Creations, LLC

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

41

-

-

-

-

-

-

-

-

-

-

-

-

Restricted short-term investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

50

50

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

1,316

1,308

1,365

1,401

1,658

837

1,114

982

851

714

943

786

925

938

1,162

489

779

786

685

436

413

241

335

324

123

105

506

340

204

61

76

45

63

14

74

70

60

Note receivable, current portion

-

-

-

-

-

-

0

0

137

95

95

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

596

383

117

-

0

-

-

-

Total current assets

25,808

36,767

32,374

38,119

38,505

32,843

11,684

8,728

7,394

8,806

10,104

10,359

13,601

14,753

8,950

9,443

14,926

5,873

9,365

12,009

4,608

9,056

11,268

12,830

14,417

15,734

17,383

18,360

19,233

10,693

11,450

7,880

210

160

76

76

351

Property, plant and equipment, net

5,147

5,375

5,202

5,946

6,242

6,375

6,061

5,966

6,008

6,215

6,419

6,567

7,103

7,295

7,346

7,053

4,814

2,657

1,067

601

479

243

179

75

34

26

19

15

13

12

13

14

14

0

0

0

0

Operating lease right-of-use assets

6,431

6,559

5,939

6,069

6,195

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangible assets, net

2,345

2,337

2,291

3,154

3,112

3,059

2,964

2,894

2,876

2,860

2,884

2,934

2,948

2,972

2,994

3,087

3,100

3,135

3,170

3,064

3,154

611

627

641

-

0

-

-

-

-

-

-

-

-

-

-

-

Investment

-

-

-

-

-

-

-

-

2,438

-

4,272

5,509

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Note receivable, less current portion

-

-

-

-

-

-

0

0

256

302

305

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill

332

332

332

2,227

2,227

2,227

2,227

2,227

2,227

2,227

2,227

2,227

2,227

2,227

2,227

2,466

2,466

2,466

1,419

1,180

1,134

332

331

331

-

0

-

-

-

-

-

-

-

-

-

-

-

TOTAL ASSETS

46,893

59,085

54,698

65,157

66,510

49,451

28,289

26,328

21,199

23,917

26,211

27,596

25,879

27,247

21,517

22,049

25,306

14,131

15,021

16,854

9,375

10,242

12,407

13,879

14,451

15,761

17,403

18,376

19,246

10,705

11,463

7,895

224

160

76

76

352

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable and accrued expenses

7,527

7,702

8,144

6,943

6,143

6,250

5,931

4,663

3,883

3,885

4,035

3,344

3,920

3,538

3,795

3,956

4,253

3,407

1,917

1,181

1,145

787

804

750

457

311

725

868

700

691

594

423

-

218

-

-

-

Accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

256

-

178

176

73

Accounts payable - related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

56

-

-

-

Due to related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

27

-

-

Accrued Phase 3 expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

55

55

55

-

55

55

55

55

111

111

111

Accrued payroll and related liabilities

2,450

2,117

1,728

1,576

1,092

2,283

1,727

1,796

1,042

1,209

1,290

1,481

980

1,638

1,291

1,132

667

1,200

1,096

707

852

716

715

553

198

338

274

182

91

18

19

11

9

0

118

118

69

Deferred revenue and customer deposits

60

57

48

224

359

119

-

-

-

29

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue and customer deposits

-

-

-

-

-

-

98

34

73

-

8

8

8

91

55

26

50

65

21

73

17

2

2

0

-

0

-

-

-

-

-

-

-

-

-

-

-

Current portion of deferred acquisition obligation and accrued interest

-

-

-

-

-

-

0

0

0

53

158

158

209

207

205

203

202

198

198

196

195

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of contingent acquisition obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

483

483

483

483

0

31

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of note payable, net of unamortized debt discount

2,546

1,772

1,007

247

2,552

2,529

1,729

992

270

-

0

0

6,187

3,973

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of operating lease obligations

634

629

496

496

511

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of finance lease obligations

7

7

5

370

-

720

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of finance lease obligations, net of unamortized discount

-

-

-

-

553

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of contingent acquisition obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

31

31

-

0

-

-

-

-

-

-

-

-

-

-

-

Current portion of capital lease obligations, net of unamortized discount

-

-

-

-

-

-

883

674

636

598

562

526

491

458

434

8

15

21

27

27

27

24

23

6

-

0

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

1

0

-

0

0

0

100

100

100

80

Notes payable and accrued interest - related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

608

300

-

-

-

Convertible note payable and accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1,130

1,111

1,092

0

Total current liabilities

13,224

12,284

11,428

9,856

11,210

11,901

10,368

8,159

5,904

5,774

6,053

5,517

11,795

9,905

5,780

5,325

5,670

5,374

3,742

2,667

2,236

1,560

1,577

1,341

655

650

1,058

1,107

848

709

669

491

930

1,860

1,647

1,598

335

Operating lease obligations, net of current portion

6,212

6,338

5,849

5,976

6,083

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Finance lease obligations, net of current portion

24

26

29

29

32

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Capital lease obligations, net of current portion and unamortized discount

-

-

-

-

-

-

0

363

546

720

883

1,038

1,182

1,318

1,439

0

0

1

1

8

12

19

25

10

-

0

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

38

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingent acquisition obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

483

483

483

483

-

0

-

-

-

-

-

-

-

-

-

-

-

Deferred acquisition obligation, net of current portion

-

-

-

-

-

-

-

-

-

-

0

0

0

52

104

156

206

258

306

355

403

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses, net of current portion

800

800

800

800

800

800

800

800

800

800

800

667

667

667

585

500

500

500

511

523

35

30

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liability

-

-

-

-

-

-

-

-

-

-

852

880

908

936

1,047

1,047

1,047

1,047

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Note payable, net of current portion and unamortized debt discount

11,605

12,219

12,865

13,498

11,351

11,999

12,668

13,274

13,866

14,008

13,877

11,848

6,010

7,937

8,816

8,655

-

8,336

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible note payable, net of unamortized debt discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

914

758

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Note payable and paid-in-kind interest, net of unamortized debt discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,495

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible note payable, net of unamortized debt discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

604

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Note payable and paid-in-kind interest, net of unamoritzed debt discount and issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,217

8,061

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible note payable and accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

1,055

TOTAL LIABILITIES

31,865

31,667

30,971

30,159

29,476

24,700

23,836

22,596

21,116

21,302

22,465

19,950

20,562

20,815

18,685

16,441

16,522

15,516

12,777

11,614

3,169

2,092

2,123

1,835

-

650

-

-

-

-

-

-

-

-

1,647

1,598

1,390

Commitments and contingencies

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

-

0

0

0

0

-

0

-

-

0

0

0

0

0

COMMITMENTS AND CONTIGENCIES STOCKHOLDERS' EQUITY
Preferred stock, $0.001 par value, 5,000,000 shares authorized, and no shares issued and outstanding at December 31, 2018 and 2017

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

Common stock, $0.001 par value, 50,000,000 shares authorized, 25,618,918 and 25,526,931 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

26

26

25

25

25

24

23

21

21

21

20

20

20

19

13

13

13

10

10

10

9

9

9

9

9

8

8

8

8

6

33

29

11

0

15

15

15

Additional paid-in capital

-

-

-

-

-

-

96,771

-

-

-

89,791

87,999

87,154

-

73,568

72,494

71,031

56,369

54,874

53,918

51,155

50,006

49,394

-

-

46,849

-

-

-

-

-

-

-

-

-

-

-

Additional paid-in capital

102,261

101,728

100,630

100,271

99,887

98,938

-

93,538

92,411

91,430

-

-

-

83,264

-

-

-

-

-

-

-

-

-

48,703

47,859

-

46,201

45,047

43,958

34,093

33,411

28,779

19,182

16,820

16,561

16,525

16,412

Accumulated deficit

-86,950

-74,043

-76,700

-65,231

-62,853

-74,211

-92,341

-89,827

-92,349

-88,836

-86,065

-80,373

-81,857

-76,851

-70,749

-66,899

-62,260

-57,764

-52,640

-48,688

-44,958

-41,865

-39,120

-36,668

-

-31,747

-

-

-

-

-

-

-

-

-

-

-

Deficit accumulated during the development stage

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

34,072

-

29,865

27,787

25,569

24,104

22,651

21,405

19,899

18,520

18,148

18,063

17,466

TOTAL HARROW HEALTH STOCKHOLDERS' EQUITY

15,337

27,711

23,955

35,065

37,059

24,751

4,453

3,722

83

2,615

3,746

7,646

5,317

6,432

2,832

5,608

8,784

-1,385

2,244

5,240

6,206

8,150

10,283

12,043

13,796

15,110

16,344

17,268

18,398

9,996

10,794

7,403

-705

-1,700

-1,571

-1,522

-1,038

Noncontrolling interests

-309

-293

-228

-67

-25

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

TOTAL EQUITY

15,028

27,418

23,727

34,998

37,034

24,751

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

TOTAL LIABILITIES AND EQUITY

46,893

59,085

54,698

65,157

66,510

49,451

28,289

26,328

21,199

23,917

26,211

27,596

25,879

27,247

21,517

22,049

25,306

14,131

15,021

16,854

9,375

10,242

12,407

13,879

14,451

15,761

17,403

18,376

19,246

10,705

11,463

7,895

224

160

76

76

352

Eton Pharmaceuticals [Member]
Investment

-

-

-

-

28,000

-

-

-

-

3,507

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Surface Pharmaceuticals [Member]
Investment

3,408

3,747

4,043

4,443

4,704

4,947

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Melt Pharmaceuticals [Member]
Investment

3,422

3,968

4,517

5,199

5,525

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-